The Cardiac Prosthetic Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Cardiac Prosthetic Devices Market:
https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report
According to The Business Research Company’s Cardiac Prosthetic Devices Global Market Report 2024, The cardiac prosthetic devices market size has grown rapidly in recent years. It will grow from $7.40 billion in 2023 to $8.20 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the increasing elderly population with a higher prevalence of cardiovascular diseases, rising incidence of cardiovascular diseases, improved surgical techniques, greater awareness among patients and healthcare providers about cardiac health, and supportive government policies and funding for cardiovascular health programs.
The cardiac prosthetic devices market size is expected to see rapid growth in the next few years. It will grow to $12.56 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the increasing elderly population prone to cardiovascular diseases, increased spending on healthcare services and devices, favorable insurance and reimbursement scenarios, increased patient preference for advanced treatment options, and higher prevalence of lifestyle-related heart conditions. Major trends in the forecast period include the development of smaller, more efficient cardiac prosthetic devices for minimally invasive procedures, advanced biocompatible materials, integration with wearable technology, improvements in battery technology, and utilization of 3d printing technology.
The prevalence of cardiovascular diseases is expected to propel the growth of the cardiac prosthetic devices market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The prevalence of cardiovascular diseases is due to unhealthy lifestyles, high rates of obesity, poor diet, lack of physical activity, high-stress levels, and an aging population. Cardiac prosthetic devices play a significant role in managing cardiovascular diseases by supporting or replacing the heart’s function or its components. For instance, in December 2022, according to the Office for National Statistics, a UK-based government department, 3.6 million people had a cardiovascular ailment (6.4%), 3.7 million had a respiratory disease (6.8%), and 6.6 million had one of these conditions (12.1%) on March 21, 2021. Therefore, the prevalence of cardiovascular diseases is driving the growth of the cardiac prosthetic devices market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18283&type=smp
The cardiac prosthetic devices market covered in this report is segmented –
1) By Type: Valves, Pacemakers
2) By Applications: Surgery, Research
3) By End User: Hospitals, Clinics Or Cardiac Centers, Ambulatory Surgical Centers, Other End-Users
Major companies operating in the cardiac prosthetic devices market are focused on developing innovative technologies, such as transcatheter pacing systems, to enhance cardiac function, reduce procedural invasiveness, and improve patient outcomes in managing heart rhythm disorders. A transcatheter pacing system is a minimally invasive device implanted via a catheter to regulate the heart’s electrical activity without needing external wires or surgery. For instance, in January 2022, Medtronic plc, an Ireland-based medical device company, launched the Micra AV Transcatheter Pacing System, a compact and minimally invasive device designed to address bradycardia (slow heart rate). The Micra AV TPS is designed to provide precise and reliable pacing for patients with bradycardia, incorporating advanced technology to synchronize pacing with the heart’s natural rhythm. Its compact size and internal battery contribute to a longer lifespan, while the remote monitoring capabilities enable healthcare providers to track the device’s performance and patient outcomes more effectively.
The cardiac prosthetic devices market report table of contents includes:
1. Executive Summary
2. Cardiac Prosthetic Devices Market Characteristics
3. Cardiac Prosthetic Devices Market Trends And Strategies
4. Cardiac Prosthetic Devices Market – Macro Economic Scenario
5. Global Cardiac Prosthetic Devices Market Size and Growth
.
.
.
32. Global Cardiac Prosthetic Devices Market Competitive Benchmarking
33. Global Cardiac Prosthetic Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cardiac Prosthetic Devices Market
35. Cardiac Prosthetic Devices Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
